Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogue

Biomedicine and Pharmacotherapy

Volumn 51, Issue 3, 1997, Pages 131-136

  Diouf, O ^a,b   Bourhim, M ^b   Lambert, D M ^c   Poupaert, J H ^c   Stables, J P ^d   Vamecq, J ^a,b  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d Preclinical Pharmacological Section   (United States)

Author keywords

4 amino N (2 ethylphenyl)benzamide; 4 aminobenzamide pharmacophore; ameltolide; anticonvulsant activity; antiepileptic drug; neurotoxicity; phenytoin

Indexed keywords

4 AMINO N (2 ETHYLPHENYL)BENZAMIDE; AMELTOLIDE; PHENYTOIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0030930992     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86911-9     Document Type: Article

References (14)

1. 1 Bailleux V, Vallée L, Nuyts JP, Vamecq J. Anticonvulsant activity of some 4-amino-N-phenylphthalimides and N-(3-amino-2-methylphenyl)phthalimides. Biomed Pharmacother 1994;48:95
2. 2 Bailleux V, Vallée L, Nuyts JP et al. Synthesis and anticonvulsant activity of some 4-nitro-N-phenylbenzamides. Eur J Med Chem 1995;30:439
3. 3 Bailleux V, Vallée L, Nuyts JP et al. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)phthalimide and prototype antiepileptic drugs in mice and rats. Epilepsia 1995;36:559
4. 4 Clark CR. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)benzamide and prototype antiepileptic drugs in mice and rats. Epilepsia 1988;29:198
5. 5 Clark CR, Davenport TW. Synthesis and anticonvulsant activity of analogues of 4-amino-N-(1-phenylethyl)benzamide. J Med Chem 1987;30:1214
6. 6 Clark CR, Lin CM, Sansom RT. Anticonvulsant activity of 2-and 3-aminobenzanilides. J Med Chem 1986;29:1534
7. 7 Clark CR, Sansom RT, Lin CM, Norris GN. Anticonvulsant activity of some 4-aminobenzanilides. J Med Chem 1985;28:1259
8. 8 Clark CR, Wells MJM, Sansom RT, Norris GN, Dockens RC, Ravis WR. Anticonvulsant activity of some 4-aminobenzamides. J Med Chem 1984;27:779
9. 9 Krall RL, Penry JK, White EG, Kupferberg HJ, Swinyard EA. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978;19:409
10. 10 Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia 1992;33:573
11. 11 Leander JD, Lawson RR, Robertson DW. Anticonvulsant effects of a novel aminobenzamide (LY201116) in mice. Neuropharmacology 1988;27:623
12. 12 Leander JD, Robertson DW, Clark CR, Lawson, Rathbun RC. Pharmacological effects of enantiomers of 4-amino-N-(α-methylbenzyl)benzamide, a chemically novel anticonvulsant. Epilepsia 1988;29:83
13. 13 Orlof MJ, Williams HL, Pfeiffer CC. Timed intravenous infusion of metrazol and strychnine for testing anticonvulsant drugs. Proc Soc Exp Biol Med 1949;70:254
14. 14 Porter RJ, Cereghino JJ, Gladding GD et al. Antiepileptic drug development programm. Cleve Clin Q 1984;51:293